- Home
- MCRB vs GORO Comparison
MCRB vs GORO Comparison
Compare MCRB & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- GORO
- Stock Information
- Founded
- MCRB 2010
- GORO 1998
- Country
- MCRB United States
- GORO United States
- Employees
- MCRB N/A
- GORO N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- GORO Precious Metals
- Sector
- MCRB Health Care
- GORO Basic Materials
- Exchange
- MCRB Nasdaq
- GORO Nasdaq
- Market Cap
- MCRB 144.6M
- GORO 133.7M
- IPO Year
- MCRB 2015
- GORO N/A
- Fundamental
- Price
- MCRB $17.75
- GORO $0.80
- Analyst Decision
- MCRB Hold
- GORO Strong Buy
- Analyst Count
- MCRB 4
- GORO 2
- Target Price
- MCRB $14.33
- GORO $1.38
- AVG Volume (30 Days)
- MCRB 101.5K
- GORO 3.2M
- Earning Date
- MCRB 11-12-2025
- GORO 11-06-2025
- Dividend Yield
- MCRB N/A
- GORO N/A
- EPS Growth
- MCRB N/A
- GORO N/A
- EPS
- MCRB 10.22
- GORO N/A
- Revenue
- MCRB N/A
- GORO $49,824,000.00
- Revenue This Year
- MCRB N/A
- GORO N/A
- Revenue Next Year
- MCRB N/A
- GORO $117.97
- P/E Ratio
- MCRB $1.74
- GORO N/A
- Revenue Growth
- MCRB N/A
- GORO N/A
- 52 Week Low
- MCRB $6.53
- GORO $0.12
- 52 Week High
- MCRB $24.67
- GORO $1.18
- Technical
- Relative Strength Index (RSI)
- MCRB 42.40
- GORO 47.34
- Support Level
- MCRB $17.63
- GORO $0.77
- Resistance Level
- MCRB $19.30
- GORO $1.18
- Average True Range (ATR)
- MCRB 1.12
- GORO 0.09
- MACD
- MCRB -0.29
- GORO -0.02
- Stochastic Oscillator
- MCRB 5.42
- GORO 5.90
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.